Current Infectious Disease Reports

, Volume 8, Issue 1, pp 35–42

Malaria: Diagnosis and treatment of falciparum malaria in travelers during and after travel


DOI: 10.1007/s11908-006-0033-5

Cite this article as:
Magill, A.J. Curr Infect Dis Rep (2006) 8: 35. doi:10.1007/s11908-006-0033-5


Plasmodium falciparum is responsible for most of the mortality in travelers related to imported malaria. Problems that occur during travel include the inaccuracy of a microscopic diagnosis of malaria, both false positives and false negatives, when ill travelers seek care while abroad. A false positive diagnosis can result in unnecessary parenteral injections that carry a risk of transmission of blood-borne pathogens, receipt of potentially dangerous drugs such as halofantrine, or receipt of fake, counterfeit drugs. Increased morbidity and mortality are associated with delays in diagnosis and initiation of prompt treatment for falciparum malaria. Availability of expert microscopy to confirm the diagnosis of malaria is limited. The presence of splenomegaly and thrombocytopenia are strongly associated with malaria and would justify empiric treatment. The availability of atovaquone-proguanil, a safe and well tolerated oral drug, should prompt a reconsideration of current treatment recommendations that discourage empiric treatment on clinical suspicion alone.

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Division of Experimental TherapeuticsWalter Reed Army Instituteof ResearchSilver SpringUSA